Optimizing Therapy for Patients with Acute and Chronic Graft-Versus-Host Disease (GvHD) - Episode 2

Improving Patient Outcomes: Prophylactic Options in Graft-Versus-Host Disease

, , ,

Panelists Hannah Choe, MD, and Bart L Scott, MD share insights concerning prophylaxis in Graft-Versus-Host Disease, including key study data and current standards of care as well as discuss the potential role of biomarkers in GvHD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Understanding Chronic and Acute Graft-Versus-Host Disease Presentation and Diagnosis
    Now Viewing
    EP. 2: Improving Patient Outcomes: Prophylactic Options in Graft-Versus-Host Disease
    EP. 3: Optimal First-Line Treatment Approaches for Acute GvHD
    EP. 4: Treatment Options in Steroid-Refractory Acute GvHD
    EP. 5: Enhancing Patient Care in Acute GvHD: Supportive Measures
    EP. 6: Advancements and Promising Directions in Acute GvHD
    EP. 7: Establishing Treatment Objectives for Chronic GvHD: First-Line Strategies
    EP. 8: A Comprehensive Look at Initial Treatment Options for Chronic GvHD
    EP. 9: Data-Driven Treatment Selection for Patients with Chronic GvHD
    EP. 10: Remote Patient Monitoring and Supportive Care Measures in Chronic GvHD
    EP. 11: The Future of Chronic GvHD Treatment
    EP. 12: Dr Rifkin on the Role of Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma
    x